Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report.
Di Palma M, Gentilini E, Masucci C, Micozzi A, Turriziani O, Mulè A, Foà R, Martelli M, D'Ettorre G, Capria S, Chiaretti S.
Di Palma M, et al. Among authors: micozzi a.
Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022043. doi: 10.4084/MJHID.2022.043. eCollection 2022.
Mediterr J Hematol Infect Dis. 2022.
PMID: 35615334
Free PMC article.